NO20081948L - Heksahydro-cykloheptapyrazol cannabinoide modulatorer - Google Patents
Heksahydro-cykloheptapyrazol cannabinoide modulatorerInfo
- Publication number
- NO20081948L NO20081948L NO20081948A NO20081948A NO20081948L NO 20081948 L NO20081948 L NO 20081948L NO 20081948 A NO20081948 A NO 20081948A NO 20081948 A NO20081948 A NO 20081948A NO 20081948 L NO20081948 L NO 20081948L
- Authority
- NO
- Norway
- Prior art keywords
- hexahydro
- cannabinoid modulators
- cycloheptapyrazole
- cycloheptapyrazole cannabinoid
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72025305P | 2005-09-23 | 2005-09-23 | |
| PCT/US2006/036158 WO2007038036A1 (en) | 2005-09-23 | 2006-09-18 | Hexahydro-cycloheptapyrazole cannabinoid modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081948L true NO20081948L (no) | 2008-06-20 |
Family
ID=37635790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081948A NO20081948L (no) | 2005-09-23 | 2008-04-23 | Heksahydro-cykloheptapyrazol cannabinoide modulatorer |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070123578A1 (de) |
| EP (1) | EP1937259B1 (de) |
| JP (1) | JP2009508953A (de) |
| KR (1) | KR20080050522A (de) |
| CN (1) | CN101312726A (de) |
| AT (1) | ATE534387T1 (de) |
| AU (1) | AU2006295121B2 (de) |
| BR (1) | BRPI0616402A2 (de) |
| CA (1) | CA2623745A1 (de) |
| CR (1) | CR9917A (de) |
| CY (1) | CY1112426T1 (de) |
| DK (1) | DK1937259T3 (de) |
| EA (1) | EA200800890A1 (de) |
| EC (1) | ECSP088314A (de) |
| ES (1) | ES2375213T3 (de) |
| HR (1) | HRP20120159T1 (de) |
| IL (1) | IL190347A0 (de) |
| NO (1) | NO20081948L (de) |
| PL (1) | PL1937259T3 (de) |
| PT (1) | PT1937259E (de) |
| RS (1) | RS52195B (de) |
| SI (1) | SI1937259T1 (de) |
| WO (1) | WO2007038036A1 (de) |
| ZA (1) | ZA200803532B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8378096B2 (en) | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
| US8378117B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
| JP2010522181A (ja) * | 2007-03-21 | 2010-07-01 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｃｂ２受容体介在疼痛を処置する方法 |
| CN102282147B (zh) * | 2009-01-28 | 2015-09-30 | 卡拉治疗学股份有限公司 | 二环吡唑并-杂环 |
| GB201706102D0 (en) * | 2017-04-18 | 2017-05-31 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
| CN122555695A (zh) | 2023-11-29 | 2026-08-11 | 爱克堤欧生物科学股份有限公司 | 可用作kcnt1抑制剂的杂环化合物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2948718A (en) * | 1960-08-09 | New n-heterocyclic compounds | ||
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| PL124029B1 (en) * | 1979-06-01 | 1982-12-31 | Wellcome Found | Process for preparing novel derivatives of 1,2,4-triazine |
| LU83729A1 (fr) * | 1981-11-04 | 1983-09-01 | Galephar | Sels d'acide valproique,leur preparation et leur utilisation |
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US5242942A (en) * | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
| FR2800375B1 (fr) * | 1999-11-03 | 2004-07-23 | Sanofi Synthelabo | Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant |
| FR2800372B1 (fr) * | 1999-11-03 | 2001-12-07 | Sanofi Synthelabo | Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant |
| JPWO2005063241A1 (ja) * | 2003-12-26 | 2007-07-19 | 小野薬品工業株式会社 | ミトコンドリアベンゾジアゼピン受容体介在性疾患の予防および／または治療剤 |
| US7452997B2 (en) * | 2004-03-24 | 2008-11-18 | Janssen Pharmaceutica, N.V. | Tetrahydro-indazole cannabinoid modulators |
| FR2875230A1 (fr) * | 2004-09-13 | 2006-03-17 | Sanofi Aventis Sa | Derives de pyrazole condense, leur preparation et leur application en therapeutique |
-
2006
- 2006-09-18 ES ES06814802T patent/ES2375213T3/es active Active
- 2006-09-18 PT PT06814802T patent/PT1937259E/pt unknown
- 2006-09-18 KR KR1020087009625A patent/KR20080050522A/ko not_active Withdrawn
- 2006-09-18 CN CNA200680043569XA patent/CN101312726A/zh active Pending
- 2006-09-18 CA CA002623745A patent/CA2623745A1/en not_active Abandoned
- 2006-09-18 AU AU2006295121A patent/AU2006295121B2/en not_active Ceased
- 2006-09-18 JP JP2008532297A patent/JP2009508953A/ja active Pending
- 2006-09-18 EP EP06814802A patent/EP1937259B1/de active Active
- 2006-09-18 US US11/522,771 patent/US20070123578A1/en not_active Abandoned
- 2006-09-18 PL PL06814802T patent/PL1937259T3/pl unknown
- 2006-09-18 EA EA200800890A patent/EA200800890A1/ru unknown
- 2006-09-18 SI SI200631246T patent/SI1937259T1/sl unknown
- 2006-09-18 BR BRPI0616402-1A patent/BRPI0616402A2/pt not_active Application Discontinuation
- 2006-09-18 AT AT06814802T patent/ATE534387T1/de active
- 2006-09-18 WO PCT/US2006/036158 patent/WO2007038036A1/en not_active Ceased
- 2006-09-18 DK DK06814802.2T patent/DK1937259T3/da active
- 2006-09-18 HR HR20120159T patent/HRP20120159T1/hr unknown
- 2006-09-18 RS RS20120064A patent/RS52195B/sr unknown
-
2008
- 2008-03-20 IL IL190347A patent/IL190347A0/en unknown
- 2008-03-26 EC EC2008008314A patent/ECSP088314A/es unknown
- 2008-04-22 ZA ZA200803532A patent/ZA200803532B/xx unknown
- 2008-04-23 NO NO20081948A patent/NO20081948L/no not_active Application Discontinuation
- 2008-04-23 CR CR9917A patent/CR9917A/es not_active Application Discontinuation
-
2012
- 2012-02-09 CY CY20121100138T patent/CY1112426T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20070123578A1 (en) | 2007-05-31 |
| KR20080050522A (ko) | 2008-06-05 |
| ECSP088314A (es) | 2008-04-28 |
| AU2006295121B2 (en) | 2011-10-27 |
| ZA200803532B (en) | 2009-09-30 |
| ATE534387T1 (de) | 2011-12-15 |
| EP1937259A1 (de) | 2008-07-02 |
| CN101312726A (zh) | 2008-11-26 |
| HRP20120159T1 (hr) | 2012-03-31 |
| WO2007038036A1 (en) | 2007-04-05 |
| EA200800890A1 (ru) | 2009-02-27 |
| CA2623745A1 (en) | 2007-04-05 |
| RS52195B (sr) | 2012-10-31 |
| CR9917A (es) | 2008-09-09 |
| IL190347A0 (en) | 2009-09-22 |
| DK1937259T3 (da) | 2012-02-13 |
| JP2009508953A (ja) | 2009-03-05 |
| AU2006295121A1 (en) | 2007-04-05 |
| BRPI0616402A2 (pt) | 2011-06-21 |
| EP1937259B1 (de) | 2011-11-23 |
| CY1112426T1 (el) | 2015-12-09 |
| PT1937259E (pt) | 2012-01-17 |
| ES2375213T3 (es) | 2012-02-27 |
| PL1937259T3 (pl) | 2012-04-30 |
| SI1937259T1 (sl) | 2012-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081949L (no) | Tetrahydro-indazolyl cannabinoide modulatorer | |
| UA107175C2 (uk) | Спосіб і сполука, призначені для одержання інгібіторів контранспортера натрій-глюкози 2 типу, варіанти | |
| NO20064810L (no) | Tetrahydro-indazolcannabinoid-modulatorer | |
| ECSP088854A (es) | Moduladores bencimidazolicos de vr1 | |
| NO20084278L (no) | Bezothiazol derivatives as beta2 adrenoreceptor agonists | |
| NO20075693L (no) | Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme | |
| BRPI0615705A2 (pt) | processo para preparar um composto, e, composto | |
| CY1112467T1 (el) | Παραγωγα 1-θειο-d-γλυκιτολης | |
| EA200602179A1 (ru) | Замещенные производные арила и гетероарила в качестве модуляторов метаболизма и для профилактики и лечения связанных с ним расстройств | |
| AU2008303600A8 (en) | 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives | |
| CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
| WO2007115315A3 (en) | Pyrrolo- and thiazolo-pyridine compounds as hif modulators | |
| EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| EA201000883A1 (ru) | Производные индолинона и способ их получения | |
| GT200600327A (es) | Ciclohexilaminoisoquinolona | |
| NO20060202L (no) | Pyrrolodihydroisokinoliner som PDE-10-inhibitorer | |
| EA200900945A1 (ru) | Новый способ синтеза агомелатина | |
| NO20090994L (no) | 2-aminobenzoxazol karboxamider som 5HT3 modulatorer | |
| BRPI0518203A2 (pt) | mÉtodos para preparaÇço de compostos indazol | |
| NO20082505L (no) | Substtuert 5-heteroaryl-1-fenyl-pyrazol-cannabinoid-modulatorer | |
| NO20071012L (no) | Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat | |
| NO20081621L (no) | Tetrahydrokinoliner, syntese og intermediater | |
| WO2007053765A3 (en) | Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase | |
| NO20074047L (no) | Ny fremgangsmate for fremstilling av substituerte indoler | |
| WO2009040314A3 (de) | Neue heteroarylsubstituierte acetonderivate, geeignet zur hemmung der phospholipase a2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |